Abstract
Size and zeta potential are critical physicochemical properties of nanoparticles (NPs), influencing their biological activity and safety profile. These are essential for further industrial upscale and clinical success. However, the characterization of polydisperse, non-spherical NPs is a challenge for traditional characterization techniques (ex., dynamic light scattering (DLS)). In this paper, superparamagnetic iron oxide nanoparticles (SPIONs) were coated with polyvinyl alcohol (PVAL) exhibiting different terminal groups at their surface, either hydroxyl (OH), carboxyl (COOH) or amino (NH2) end groups. Size, zeta potential and concentration were characterized by orthogonal methods, namely, batch DLS, nanoparticle tracking analysis (NTA), tunable resistive pulse sensing (TRPS), transmission electron microscopy (TEM), asymmetric flow field flow fractionation (AF4) coupled to multi-angle light scattering (MALS), UV–Visible and online DLS. Finally, coated SPIONs were incubated with albumin, and size changes were monitored by AF4-MALS-UV-DLS. NTA showed the biggest mean sizes, even though DLS PVAL-COOH SPION graphs presented aggregates in the micrometer range. TRPS detected more NPs in suspension than NTA. Finally, AF4-MALS-UV-DLS could successfully resolve the different sizes of the coated SPION suspensions. The results highlight the importance of combining techniques with different principles for NPs characterization. The advantages and limitations of each method are discussed here.
Funder
Bourgogne Franche-Comté Graduate School EUR-EIPHI
ANER project “Nanoprot”
French National Research Agency (ANR) as part of the “Investments d’Avenir” Programme
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis
Reference44 articles.
1. Characterization of nanoparticles-based vaccines for COVID-19;Guerrini;Nat. Nanotechnol.,2022
2. On the issue of transparency and reproducibility in nanomedicine;Leong;Nat. Nanotechnol.,2019
3. The need for robust characterization of nanomaterials for nanomedicine applications;Mahmoudi;Nat. Commun.,2021
4. Delivering the power of nanomedicine to patients today;Germain;J. Control. Release,2020
5. Commission, E., Centre, J.R., Box, H., Bremer-Hoffmann, S., Gaitan, S., Del Pozo, A., Elk, M., Geertsma, R., Gainza Lafuente, E., and Roesslein, M. (2019). Anticipation of Regulatory Needs for Nanotechnology-Enabled Health Products: The REFINE White Paper, Publications Office of the European Union.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献